Cancer Research UK Clinical Trials Unit, Birmingham - Adult Unit

Bach, Simon (Co-Investigator)
Bowden, Sarah (Co-Investigator)
Craddock, Charles (Co-Investigator)
Rea, Daniel (Co-Investigator)
Kearns, Pamela (Principal Investigator)
Wheatley, Keith (Co-Investigator)
Billingham, Lucinda (Co-Investigator)
Steven, Neil (Co-Investigator)

6 Article

6 results

2024
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Mehanna, H., Gaunt, P., Kong, A., Hartley, A., Sanghera, P., Forster, M., Sen, M., Paleri, V., Fong, C., Geropantas, D., Srinivasan, D., Garikipati, S., Moleron, R., Casswell, G., Aynsley, E., Ward, A., O'Toole, L., Mirza, A., Firth, C., Humphreys, I., & 2 othersFulton-Lieuw, T. & Nankivell, P., 15 Jan 2024, In: Trials. 25, 50.
Research output: Contribution to journal › Article › peer-review

Open Access
File
16 Downloads (Pure)
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer
Kong, A., Kirkham, A. J., Savage, J. S., Mant, R., Lax, S., Good, J., Forster, M. D., Sacco, J. J., Schipani, S., Harrington, K. J., Yap, C. & Mehanna, H., 29 Jan 2024, In: BJC Reports. 2, 1, 9 p., 6.
Research output: Contribution to journal › Article › peer-review

Open Access
File
18 Downloads (Pure)
2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
PITCH Consortium, CONSENSUS & OCTAVE Collaborative Group, 6 Jul 2023, (E-pub ahead of print) In: Nature Medicine.
Research output: Contribution to journal › Article › peer-review

Open Access
File
13 Downloads (Pure)
Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
SELENIB Investigators, Bryan, R., Pirrie, S., Abbotts, B., Maycock, S., During, V., Lewis, C., Grant, M., Bird, D., Devall, A., Wallace, D. M., James, N., Billingham, L., Zeegers, M. & Cheng, KK., 17 Oct 2023, In: JAMA network open. 6, 10, 10 p., e2337494.
Research output: Contribution to journal › Article › peer-review

Open Access
File
29 Downloads (Pure)
2022
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
CANTATA investigators, 18 Jun 2022, (E-pub ahead of print) In: BJUI Compass.
Research output: Contribution to journal › Article › peer-review

Open Access
File
45 Downloads (Pure)
2021
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)
Pascoe, J., Jackson, A., Gaskell, C., Gaunt, C., Thompson, J., Billingham, L. & Steven, N., 12 Jul 2021, In: BMC Cancer. 21, 1, 800.
Research output: Contribution to journal › Article › peer-review

Open Access
File
135 Downloads (Pure)

Cancer Research UK Clinical Trials Unit, Birmingham - Adult Unit

Research output

Search results

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)